닥플 플러스
18th WSC combined with ICSU 2026 (1일차)
대한뇌졸중학회
연수평점 :5점
오프라인
주관
대한뇌졸중학회
교육일자
2026-10-21
수강료
1,400,000원
교육형태
오프라인
등록일시
2026-09-05
교육시간
38시간 16분
연수평점
5점
장소
서울특별시 코엑스
교육종류
신경외과, 영상의학과, 신경과, 재활의학과
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-10-21 | 08:00~08:12 | 구연)EVT PLUS STANDARD CARE VS STANDARD CARE ALONE FOR SEVERE CVST IN MENA: THE REVIVE‑CVST RANDOMIZED TRIAL | Ossama Y. Mansour(alexandria university, Egypt) | - |
| 2026-10-21 | 08:12~08:24 | 구연)EFFECT OF STROKE ETIOLOGY ON OUTCOMES OF TENECTEPLASE PLUS THROMBECTOMY VERSUS THROMBECTOMY ALONE: A SECONDARY ANALYSIS OF THE BRIDGE-TNK TRIAL | Zhongfan Ruan(The First Affiliated Hospital, Hengyang Medical School, University of South China) | - |
| 2026-10-21 | 08:24~08:36 | 구연)ENDOVASCULAR THERAPY FOR NON-MINOR MDVO STROKE IN PATIENTS INELIGIBLE FOR INTRAVENOUS THROMBOLYSIS: A SECONDARY ANALYSIS OF THE DISTAL RANDOMIZED CLINICAL TRIAL | Fabiano Cavalcante(Amsterdam UMC,Netherlands) | - |
| 2026-10-21 | 08:36~08:48 | 구연)SEVERITY-STRATIFIED THROMBECTOMY SELECTION IN MEDIUM-VESSEL OCCLUSION: A MULTICENTER COHORT STUDY | Zhi-Xin Huang(Guangdong Second Provincial General Hospital,China) | - |
| 2026-10-21 | 08:48~09:00 | 구연)EFFICACY AND SAFETY OF EDARAVONE DEXBORNEOL IN LARGE VESSEL OCCLUSION STROKE PATIENTS WITH CLINICAL-RADIOLOGICAL MISMATCH: A PRESPECIFIED SUBGROUP ANALYSIS OF THE TASTE-2 TRIAL | Zhiyuan Feng (BEIJING TIANTAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY,China) | - |
| 2026-10-21 | 09:00~09:12 | 구연)STROKE ARTIFICIAL INTELLIGENCE-BASED DETECTION IN EMERGENCIES: DEVELOPING A VIRTUAL ASSISTANT BASED ON AI TOOLS (SAIDE) | Alessandro Bufi(Azienda Ospedaliero-Universitaria Santa Maria della Misericordia Perugia) | - |
| 2026-10-21 | 09:12~09:24 | 구연)NON-STENOTIC CAROTID DISEASE IS NOT BENIGN: COMPARABLE RISK TO ≥50% STENOSIS AFTER STROKE | Nishita Singh(University of Manitoba) | - |
| 2026-10-21 | 09:24~10:00 | BREAK | - | - |
| 2026-10-21 | 10:00~10:12 | 구연)BIRCH: A PHASE IIA RANDOMIZED STUDY OF BIOX-101 IN ACUTE INTRACEREBRAL HEMORRHAGE | Dimitri Hemelsoet (Belgium)(Department of Neurology, Gent University Hospital) | - |
| 2026-10-21 | 10:12~10:24 | 구연)RELATIVE REDUCTIONS IN SYSTOLIC BLOOD PRESSURE AND FUNCTIONAL OUTCOMES IN INTRACEREBRAL HEMORRHAGE: A POOLED ANALYSIS OF FOUR INTERACT AND ATACH-2 INDIVIDUAL PARTICIPANT DATA | Xinwen Ren (Australia)(The George Institute for Global Health, Faculty of Medicine, University of New South Wales) | - |
| 2026-10-21 | 10:24~10:36 | 구연)THE ASSOCIATION BETWEEN TIME IN TARGET RANGE AND SYSTOLIC BLOOD PRESSURE LOAD AND RECURRENT STROKE AFTER INTRACEREBRAL HAEMORRHAGE | Xia Wang (Australia)(The George Institute for Global Health, Faculty of Medicine, University of New South Wales) | - |
| 2026-10-21 | 10:36~10:48 | 구연)VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY AND CARDIOVASCULAR OUTCOMES ACROSS ANTIHYPERTENSIVE REGIMENS: A TARGET TRIAL EMULATION STUDY | Yue Qiao (China)(Xuanwu Hospital, Capital Medical University) | - |
| 2026-10-21 | 10:48~11:00 | 구연)SECONDARY PREVENTION OF STROKE OR TRANSIENT ISCHEMIC ATTACK BY MEANS OF A WEIGHT REDUCTION PROGRAMME (SCENARIO TRIAL) | Yaroslav Winter (Germany)(Saarland University Medical Center, University of Saarland) | - |
| 2026-10-21 | 11:00~11:12 | 구연)ROLE OF CEREBRAL SMALL VESSEL DISEASE IN COGNITIVE DECLINE AFTER INTRACEREBRAL HAEMORRHAGE: TRIDENT MRI SUBSTUDY | Katie Harris (Australia)(The George Institute for Global Health) | - |
| 2026-10-21 | 11:12~11:24 | 구연)CEREBROLYSIN FOR THE PREVENTION OF POST-STROKE COGNITIVE DECLINE: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (CODEC) | Michael Brainin (Austria)(Danube University Krems) | - |
| 2026-10-21 | 11:24~13:00 | LUNCH | - | - |
| 2026-10-21 | 13:00~13:15 | INTENSIVE BLOOD PRESSURE MANAGEMENT PERI-THROMBECTOMY: YES | Else Charlotte Sandset (Norway)(Oslo University Hospital) | - |
| 2026-10-21 | 13:15~13:30 | INTENSIVE BLOOD PRESSURE MANAGEMENT PERI-THROMBECTOMY: NO | Georgios Tsivgoulis (Greece)(National & Kapodistrian University of Athens) | - |
| 2026-10-21 | 13:30~13:45 | ADJUNCTIVE THERAPIES DURING THROMBECTOMY: YES | Elena Zapata-Arriaza (Spain)(Servicio Andaluz de Salud) | - |
| 2026-10-21 | 13:45~14:00 | ADJUNCTIVE THERAPIES DURING THROMBECTOMY: NO | Bruce Campbell (Australia)(University of Melbourne) | - |
| 2026-10-21 | 14:00~14:30 | DISCUSSION | - | - |
| 2026-10-21 | 14:30~15:00 | BREAK | - | - |
| 2026-10-21 | 15:00~15:15 | IMAGING TO DIAGNOSE AND PREDICT RISK IN CEREBRAL SMALL VESSEL DISEASE | Frank -Erik De Leeuw (Netherlands)(Radboud University Medical Centre.) | - |
| 2026-10-21 | 15:15~15:30 | REVISED DIAGNOSTIC CRITERIA FOR VASCULAR COGNITIVE IMPAIRMENT AND DEMENTIA: THE VASCOG-2-WSO CRITERIA | Perminder Sachdev (Australia)(University of New South Wales) | - |
| 2026-10-21 | 15:30~15:45 | DO LIFESTYLE INTERVENTIONS AND EXERCISE PREVENT VASCULAR COGNITIVE IMPAIRMENT? | Christopher Chen (Singapore)(National University of Singapore) | - |
| 2026-10-21 | 15:45~16:00 | NEW TREATMENTS FOR CEREBRAL SMALL VESSEL DISEASE: WHAT DOES THE FUTURE HOLD? | Joanna M. Wardlaw (United Kingdom)(Joanna M. Wardlaw (United Kingdom)) | - |
| 2026-10-21 | 16:00~16:30 | DISCUSSION | - | - |
| 2026-10-21 | 16:30~16:45 | BREAK | - | - |
| 2026-10-21 | 16:45~16:50 | WORDS FROM THE PRESIDENT | Jeyaraj D. Pandian (India)(Christian Medical College) | - |
| 2026-10-21 | 16:50~17:00 | LOCAL WELCOME & MINISTER OF HEALTH AND WELFARE VIDEO | Keun-Sik Hong (Korea, Republic of)(Inje Univ Ilsan Paik Hospital) | - |
| 2026-10-21 | 17:00~17:05 | A WELCOME FROM THE CHAIRPERSON OF THE KOREAN STROKE SOCIETY | Jae-Kwan J. Cha (Korea, Republic of)(Dong-A University Hospital) | - |
| 2026-10-21 | 17:05~17:15 | THE POWER OF RECOVERY: RECLAIMING LIFE AFTER STROKE | Lee Hun (Korea, Republic of)() | - |
| 2026-10-21 | 17:15~17:17 | INTRODUCTION 2026 WSO AWARD FOR STROKE SERVICES | Craig S. Anderson (Australia)(The George Institute for Global Health) | - |
| 2026-10-21 | 17:17~17:32 | PRESENTATION BY 2026 WSO AWARDEE FOR STROKE SERVICES | Andrew Demchuk (Canada)(University of Calgary) | - |
| 2026-10-21 | 17:32~17:35 | SCIENTIFIC WELCOME | Luciano Sposato (Canada)(Western University) | - |
| 2026-10-21 | 17:35~17:37 | INTRODUCTION TO CLINICAL TRIALS | Luciano Sposato (Canada)(Western University) | - |
| 2026-10-21 | 17:37~17:47 | 구연)ADJUNCTIVE INTRA-ARTERIAL ALTEPLASE AFTER NEAR-COMPLETE OR COMPLETE REPERFUSION IN ACUTE ISCHEMIC STROKE: A POST HOC ANALYSIS OF THE PEARL TRIAL | Yamei Tang (China)(Sun Yat-sen Memorial Hospital) | - |
| 2026-10-21 | 17:47~17:52 | Q&A | - | - |
| 2026-10-21 | 17:52~18:02 | 구연)INTRA-ARTERIAL METHYLPREDNISOLONE FOLLOWING SUCCESSFUL REPERFUSION IN ACUTE ISCHEMIC STROKE: A PROSPECTIVE MULTICENTER RANDOMIZED PILOT TRIAL (RAPID-M) | Jiang Xu (China)(General Hospital of Xuzhou Mining Group) | - |
| 2026-10-21 | 18:02~18:07 | Q&A | - | - |
| 2026-10-21 | 18:07~18:17 | 구연)EFFECT OF EARLY TICAGRELOR‑ASPIRIN ON OUTCOMES BY INFARCTION PATTERN AFTER THROMBOLYSIS IN MILD‑TO‑MODERATE STROKE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE TAPIS TRIAL | Xiaohui Zi (China)(Beijing Tiantan Hospital Affiliated to Capital Medical University) | - |
| 2026-10-21 | 18:17~18:22 | Q&A | - | - |
| 2026-10-21 | 18:22~18:32 | 구연)PILOT STUDY FOR SMARTWATCH-DRIVEN ATRIAL FIBRILLATION DETECTION IN STROKE PATIENTS - FIND-AF 2 WATCH | Tobias Uhe (Germany)(University of Leipzig Medical Center) | - |
| 2026-10-21 | 18:32~18:37 | Q&A | - | - |
| 2026-10-21 | 18:37~18:39 | WSO INTRODUCTION TO WSO LEADERSHIP AWARD | Gisele S. Silva (Brazil)(Unifesp-Epm) | - |
| 2026-10-21 | 18:39~18:54 | WSO LEADERSHIP AWARD | Sheila C. Martins (Brazil)(Hospital Moinhos de Vento) | - |
| 2026-10-21 | 08:00~08:15 | IMAGING DIAGNOSIS OF ICAD-RELATED LVO BEFORE AND DURING EVT | Takeshi Yoshimoto (Japan)(Hiroshima City North Medical Center Asa Citizens Hospital) | - |
| 2026-10-21 | 08:15~08:30 | CLINICAL, IMAGING AND BLOOD BIOMARKERS FOR PREDICTING STROKE RECURRENCE AND OUTCOMES | Sylaja PN (India)(Sree Chitra Tirunal Institute for Medical Sciences and Technology) | - |
| 2026-10-21 | 08:30~08:45 | RE-THROMBECTOMY FOR EARLY POST-THROMBECTOMY REOCCLUSION DUE TO ICAD | Marc Ribo (Spain)(Hospital Universitari Vall d’Hebron) | - |
| 2026-10-21 | 08:45~09:00 | PEARL AND OYSTERS: INTRAARTERIAL THROMBOLYSIS AFTER THROMBECTOMY | Yamei Tang (China)(Sun Yat-sen Memorial Hospital) | - |
| 2026-10-21 | 09:00~09:30 | DISCUSSION | - | - |
| 2026-10-21 | 09:30~10:00 | BREAK | - | - |
| 2026-10-21 | 10:00~10:20 | THE ROLE OF CARDIAC CT IN ACUTE ISCHEMIC STROKE | Michele Romoli (Italy)(Bufalini Hospital) | - |
| 2026-10-21 | 10:20~10:40 | BIOMARKERS FOR CARDIOEMBOLIC SOURCES: DETECTION AND PROGNOSIS | Mira Katan (Switzerland)(University Hospital of Basel) | - |
| 2026-10-21 | 10:40~11:00 | ECHOCARDIOGRAPHY: HOW MUCH CAN WE GET FROM IT? | Jorge Pagola (Spain)(Vall d'Hebron Hospital) | - |
| 2026-10-21 | 11:00~11:30 | DISCUSSION | - | - |
| 2026-10-21 | 11:30~13:00 | LUNCH & BREAK | - | - |
| 2026-10-21 | 13:00~13:15 | USE OF NOVEL IMAGING BIOMARKERS IN CSVT | Diana Aguiar De Sousa (Portugal)(Lisbon Central University Hospita) | - |
| 2026-10-21 | 13:15~13:30 | APLA AND CSVT – DECIPHERING THE CONUNDRUM | Ronen R. Leker (Israel)(Hadassah-Hebrew University Medical Center) | - |
| 2026-10-21 | 13:30~13:45 | NOAC USE IN CSVT – DATA FROM RCTS AND REAL LIFE DATA | Thalia S. Field (Canada)(University of British Columbia) | - |
| 2026-10-21 | 13:45~14:00 | CSVT TREATMENT - NOVEL PIPELINE DRUGS AND CATHETERS | Johanna Ospel (Canada)(University of Calgary) | - |
| 2026-10-21 | 14:00~14:30 | DISCUSSION | - | - |
| 2026-10-21 | 14:30~15:00 | BREAK | - | - |
| 2026-10-21 | 15:00~15:15 | THE COMPLEX RELATIONSHIP BETWEEN STROKE AND CANCER | Yerim Kim (Korea, Republic of)(Kandong Sacred Heart Hospital, Hallym University College of Medicine) | - |
| 2026-10-21 | 15:15~15:30 | OUTCOME IN ISCHEMIC AND HEMORRHAGIC STROKE IN PATIENTS WITH CANCER: JAPAN STROKE DATA BANK | Kazunori Toyoda (Japan)(National Cerebral and Cardiovascular Center) | - |
| 2026-10-21 | 15:30~15:45 | THROMBECTOMY DILEMMA IN STROKE PATIENTS WITH ACTIVE CANCER: TO TREAT OR NOT TO TREAT? (ASIA-PACIFIC STROKE-CANCER CONSORTIUM, APEX) | Henry Ma (Australia)(Monash University) | - |
| 2026-10-21 | 15:45~16:00 | ANTITHROMBOTIC STRATEGY FOR SECONDARY PREVENTION IN CANCER PATIENTS | Deidre A. De Silva (Singapore)(National Neuroscience Institute) | - |
| 2026-10-21 | 16:00~16:30 | DISCUSSION | - | - |
| 2026-10-21 | 08:00~08:20 | SYMPTOMATIC AND ASYMPTOMATIC CAROTID DISEASE: GUIDELINES, CONTROVERSIES, AND THE CASE FOR INDIVIDUALISED DECISION-MAKING | Vasileios Lioutas (United States of America)(Beth Israel Deaconess Medical Center, Harvard Medical School) | - |
| 2026-10-21 | 08:20~08:40 | STENTING VS ENDARTERECTOMY IN EXTRACRANIAL CAROTID STENOSIS: THE GREAT CAROTID DEBATE | Ahmed Nasreldein (Egypt)(Assiut University) | - |
| 2026-10-21 | 08:40~09:00 | BEYOND ATHEROSCLEROSIS: UNCOMMON CAROTID PATHOLOGIES YOU SHOULD NOT MISS | Ivy A. Sebastian (India)(Christian Medical College, Ludhiana, Panjab, India) | - |
| 2026-10-21 | 09:00~09:30 | DISCUSSION | - | - |
| 2026-10-21 | 09:30~10:00 | BREAK | - | - |
| 2026-10-21 | 10:00~10:15 | TARGETING HEMATOMA EXPANSION: PRECISION SELECTION, HEMOSTATIC THERAPY, AND LESSONS FROM FASTEST | Dar Dowlatshahi (Canada)(University of Ottawa) | - |
| 2026-10-21 | 10:15~10:30 | WHAT'S THE DEAL WITH REVERSAL THERAPY IN 2026? | Trine Apostolaki-Hansson (Sweden)(Skåne University Hospital Malmö and Lund University) | - |
| 2026-10-21 | 10:30~10:45 | CARE BUNDLES IN ACUTE ICH: FROM ABC-ICH TO INTERACT3 TO ICATCHER | Craig S. Anderson (Australia)(The George Institute for Global Health) | - |
| 2026-10-21 | 10:45~11:00 | MEDICAL MANAGEMENT OF SEVERE ICH | Alejandro Rabinstein (United States of America)(Mayo Clinic) | - |
| 2026-10-21 | 11:00~11:30 | DISCUSSION | - | - |
| 2026-10-21 | 11:30~13:00 | LUNCH & BREAK | - | - |
| 2026-10-21 | 13:00~13:15 | TRANSITIONAL STROKE CARE: EVIDENCE, INTEGRATION, AND THE BURDEN ON FAMILIES AND COMMUNITIES | Bernadette Boden-Albala (United States of America)(University of California, Irvine) | - |
| 2026-10-21 | 13:15~13:30 | TRANSITIONAL CARE FOR STROKE SURVIVORS: FAMILY CAREGIVER BURDEN AND IMPLICATIONS FOR HEALTH SYSTEMS | Deidre A. De Silva (Singapore)(National Neuroscience Institute) | - |
| 2026-10-21 | 13:30~13:45 | BUILDING COMPREHENSIVE STROKE CARE SYSTEMS: INTEGRATING PATIENT–CAREGIVER SUPPORT AND SOCIAL CARE | Michele Nelson (Canada)(University of Ottawa) | - |
| 2026-10-21 | 13:45~14:00 | THE HIDDEN REALITIES OF STROKE CARE: PATIENT, CAREGIVER, AND HEALTH SYSTEM PERSPECTIVES | Saran Chamberlain (Australia)(Flinders University) | - |
| 2026-10-21 | 14:00~14:30 | DISCUSSION | - | - |
| 2026-10-21 | 14:30~15:00 | BREAK | - | - |
| 2026-10-21 | 15:00~15:15 | FUTURE CHALLENGES FOR STROKE REHABILITATION | Volker Hömberg (Germany)(SRH Gesundheitszentrum Bad Wimpfen) | - |
| 2026-10-21 | 15:15~15:30 | THE CONCEPT OF BRAIN RESERVE IN STROKE | Dafin Fior Muresanu (Romania)(Iuliu Hatieganu University of Medicine and Pharmacy) | - |
| 2026-10-21 | 15:30~15:45 | TOWARD PRECISION BRAIN NEUROREHABILITATION FOR STROKE: FROM "DOES IT WORK?" TO "FOR WHOM, WHEN, AND HOW?" | Nam-Jong Paik (Korea, Republic of)(Seoul National University Bundang Hospital) | - |
| 2026-10-21 | 15:45~16:00 | PERIPHERAL NERVE STIMULATION IN UPPER LIMB REHABILITATION AFTER STROKE | Adriana Conforto (Brazil)(Hospital das Clínicas/FMUSP and Hospital Israelita Albert Einstein) | - |
| 2026-10-21 | 16:00~16:15 | WSO STROKE REHABILITATION CENTER CERTIFICATION STANDARDS CRITERIA | Sean Savitz (United States of America)(UTHealth Houston) | - |
| 2026-10-21 | 16:15~16:30 | DISCUSSION | - | - |
| 2026-10-21 | 08:00~08:15 | COMMUNITY-BASED QUALITATIVE RESEARCH ON STROKE CARE IN RWANDA: EXPERIENCES AND LESSONS LEARNED | Joseph Rukelibuga (Rwanda)(Stroke Action Rwanda) | - |
| 2026-10-21 | 08:15~08:30 | MAPPING THE LIVED EXPERIENCES OF STROKE SURVIVORS TO INFORM STROKE CARE SERVICE DEVELOPMENT IN LOWER-RESOURCE SETTINGS | Sarah Belson (United Kingdom)(World Stroke Organization) | - |
| 2026-10-21 | 08:30~08:45 | CLINICAL EXPERIENCES AND PERSPECTIVES OF STROKE SURVIVORS, INFORMAL CAREGIVERS, AND HEALTHCARE PROVIDERS IN SIERRA LEONE | Daniel Youkee (Sierra Leone)(King's College London) | - |
| 2026-10-21 | 08:45~09:00 | DEVELOPING A COMPREHENSIVE STROKE CARE SYSTEM IN A LOW-RESOURCE SETTING | Debbie E. Meko (Papua New Guinea)(Port Moresby General Hospital) | - |
| 2026-10-21 | 09:00~09:30 | DISCUSSION | - | - |
| 2026-10-21 | 09:30~10:00 | BREAK | - | - |
| 2026-10-21 | 10:00~10:15 | THE BIOLOGICAL BASIS OF LATE RECOVERY: WHAT NEUROIMAGING AND NEUROSCIENCE NOW TELL US ABOUT THE POST-ACUTE WINDOW | Sean Dukelow (Canada)(University of Calgary) | - |
| 2026-10-21 | 10:15~10:30 | BEYOND THE RECOVERY CEILING: LONGITUDINAL EVIDENCE OF FUNCTIONAL RECOVERY AFTER STROKE | Kate Hayward (Australia)(University of Melbourne) | - |
| 2026-10-21 | 10:30~10:45 | LIVED EXPERIENCES OF RECOVERY AFTER STROKE: CHALLENGING THE CONVENTIONAL RECOVERY CEILING IN STROKE REHABILITATION | Misun Lee (Korea, Republic of)(Korea University) | - |
| 2026-10-21 | 10:45~11:00 | WHAT STROKE SURVIVOR ORGANIZATIONS SEE WHEN THE SYSTEM DECIDES RECOVERY IS OVER — AND WHAT THEY NEED FROM SCIENCE AND POLICY | Lisa Murphy (Australia)(Stroke Foundation) | - |
| 2026-10-21 | 11:00~11:30 | DISCUSSION | - | - |
| 2026-10-21 | 11:30~13:00 | LUNCH & BREAK | - | - |
| 2026-10-21 | 13:00~13:15 | EVIDENCE BASED RECOMMENDATIONS AND KEY QUALITY INDICATORS FOR STROKE REHABILITATION OF WSO AND ITS RELEVANCE IN A HIGH INCOME COUNTRY | Jessica Nolan (Australia)(Curtin University) | - |
| 2026-10-21 | 13:15~13:30 | PILOTING OF WSO REHAB METRICS GLOBALLY - FINDINGS AND EXPERIENCES WITH A FOCUS ON SOUTH AMERICA | Jussara A. Baggio (Brazil)(Federal University of Alagoas) | - |
| 2026-10-21 | 13:30~13:45 | CONTEXTUALIZING NATIONAL STROKE REHABILITATION GUIDELINES USING THE ADAPTE FRAMEWORK - CASE EXAMPLE FROM SINGAPORE | Li Khim Kwah (Singapore)(Singapore General Hospital) | - |
| 2026-10-21 | 13:45~14:00 | CONTEXTUALIZING NATIONAL STROKE REHABILITATION GUIDELINES USING THE ACA FRAMEWORK - CASE EXAMPLE FROM INDIA | Dorcas B. Gandhi (India)(Christian Medical College, Ludhiana, Panjab, India) | - |
| 2026-10-21 | 14:00~14:30 | DISCUSSION | - | - |
| 2026-10-21 | 14:30~15:00 | BREAK | - | - |
| 2026-10-21 | 15:00~15:11 | 구연)RNF213 VARIANT, VESSEL CALIBER, AND LONG-TERM OUTCOMES IN HR-MRI-DEFINED INTRACRANIAL ATHEROSCLEROSIS | Hyung Jun Kim (Korea, Republic of)(Samsung Medical Center) | - |
| 2026-10-21 | 15:11~15:22 | 구연)GENOTYPE–PHENOTYPE HETEROGENEITY IN CADASIL WITH EMPHASIS ON THE R544C VARIANT: A KOREAN MULTICENTER STUDY | Jay Chol Choi (Korea, Republic of)(Jeju National University Hospital, Jeju National University College of Medicine) | - |
| 2026-10-21 | 15:22~15:33 | 구연)CEREBRAL MICROBLEED BURDEN AS AN INDEPENDENT PREDICTOR OF CLINICAL OUTCOMES IN NOTCH3 R544C CADASIL | Chao-Yu Liu (Taiwan)(National Taiwan University Hospital) | - |
| 2026-10-21 | 15:33~15:44 | 구연)INTEGRATED GIGASTROKE POLYGENIC SCORE PREDICTS STROKE RISK, SUBTYPE, AND RECURRENCE IN KOREAN YOUNG ADULTS | Do Yeon Kim (Korea, Republic of)(Seoul National University Bundang Hospital) | - |
| 2026-10-21 | 15:44~15:55 | 구연)DOACS OR VITAMIN K ANTAGONISTS FOR CEREBRAL VENOUS THROMBOSIS: 2-YEAR OUTCOME DATA OF THE DOAC-CVT STUDY | Jelle J. Vellema (Netherlands)(Amsterdam UMC) | - |
| 2026-10-21 | 15:55~16:06 | 구연)IDENTIFICATION AND GENOTYPE-PHENOTYPE CORRELATION OF RNF213 P.R4810K AND NON-P.R4810K VARIANTS IN MOYAMOYA DISEASE IN AN INDIAN COHORT | Lakshmi J Nair (India)(Sree Chitra Tirunal Institute of Medical Science) | - |
| 2026-10-21 | 16:06~16:17 | 구연)OCCULT MALIGNANCY IN YOUNG ISCHEMIC STROKE PATIENTS FROM A MULTI-ETHNIC ASIAN COHORT | Hao Min Cheo (Singapore)(Yong Loo Lin School of Medicine, National University of Singapore) | - |
| 2026-10-21 | 16:17~16:28 | 구연)CIRCADIAN REGULATION OF MULTI-MODAL ENDOGENOUS BRAIN CLEARANCE SYSTEMS IN HEMATOMA RESOLUTION FOLLOWING INTRACEREBRAL HEMORRHAGE | Gaiqing Wang (China)(Sanya Central Hospital(The Third People's Hospital of Hainan Province)) | - |
| 2026-10-21 | 08:00~08:20 | 79TH WORLD HEALTH ASSEMBLY STROKE RESOLUTION AND GLOBAL HYPERTENSION CONTROL STRATEGIES FOR PREVENTION OF STROKE | Jeyaraj D. Pandian (India)(Christian Medical College) | - |
| 2026-10-21 | 08:20~08:40 | TAILORING SALT REDUCTION FOR POPULATION HYPERTENSION CONTROL AND PRIMARY AND SECONDARY STROKE PREVENTION | Daniel T. Lackland (United States of America)(Medical University of South Carolina) | - |
| 2026-10-21 | 08:40~09:00 | REDUCING STROKE THROUGH SODIUM INNOVATION: SALT SUBSTITUTION AND HYPERTENSION CONTROL | Bruce Neal (Australia)(The George Institute for Global Health) | - |
| 2026-10-21 | 09:00~09:30 | DISCUSSION | - | - |
| 2026-10-21 | 09:30~10:00 | BREAK | - | - |
| 2026-10-21 | 10:00~10:15 | THE NEXT FRONTIERS IN STROKE PREVENTION | Gisele S. Silva (Brazil)(Unifesp-Epm) | - |
| 2026-10-21 | 10:15~10:30 | THE NEXT FRONTIERS IN INTRACEREBRAL HAEMORRHAGE | Aristeidis Katsanos (Canada)(McMaster University) | - |
| 2026-10-21 | 10:30~10:45 | THE NEXT FRONTIERS IN VENOUS SINUS THROMBOSIS | Diana Aguiar De Sousa (Portugal)(Lisbon Central University Hospita) | - |
| 2026-10-21 | 10:45~11:00 | THE NEXT FRONTIERS IN ACUTE ISCHAEMIC STROKE MANAGEMENT | Urs Fischer (Switzerland)(Inselspital University Hospital) | - |
| 2026-10-21 | 11:00~11:30 | DISCUSSION | - | - |
| 2026-10-21 | 11:30~13:00 | LUNCH & BREAK | - | - |
| 2026-10-21 | 13:00~13:15 | TARGET BLOOD PRESSURE: ONE SIZE FITS ALL OR STROKE SUBTYPE-SPECIFIC? | Hye Seon Jeong (Korea, Republic of)(Chungnam National university hospital) | - |
| 2026-10-21 | 13:15~13:30 | HOW LOW SHOULD LDL-C GO AFTER STROKE: ONE GOAL OR DIFFERENT GOALS? | Joon Tae Kim (Korea, Republic of)(Chonnam National University Medical School) | - |
| 2026-10-21 | 13:30~13:45 | LATEST EVIDENCE IN PFO AND STROKE PREVENTION | Guillaume Turc (France)(Sainte-Anne Hospital) | - |
| 2026-10-21 | 13:45~14:00 | LONG-TERM DUAL ANTIPLATELET THERAPY: FRIEND OR FOE? | Clay Johnston (United States of America)(Harbor Health) | - |
| 2026-10-21 | 14:00~14:30 | DISCUSSION | - | - |
| 2026-10-21 | 14:30~15:00 | BREAK | - | - |
| 2026-10-21 | 15:00~15:15 | THE IMPORTANCE OF TRANSPORT IN STROKE CARE: WHY IT MATTERS | Gianluca De Rubeis (Italy)(San Camillo Forlanini Hospital) | - |
| 2026-10-21 | 15:15~15:30 | BARRIERS TO ACCESSING MECHANICAL THROMBECTOMY | Adnan Mujanovic (Switzerland)(University Hospital Bern Inselspital) | - |
| 2026-10-21 | 15:30~15:45 | IMPROVING PATIENT PATHWAYS FOR THROMBECTOMY: HOW TECHNOLOGY CAN FACILITATE ACCESS AND SPEED OF TREATMENT | Johanna Ospel (Canada)(University of Calgary) | - |
| 2026-10-21 | 15:45~16:00 | INTERNATIONAL INSIGHTS ON THE TRANSPORT RELATED BARRIERS TO PATIENTS ACCESSING THROMBECTOMY: FINDINGS FROM AN INTERNATIONAL SURVEY | Nishita Singh (Canada)(University of Manitoba) | - |
| 2026-10-21 | 16:00~16:30 | DISCUSSION | - | - |
| 2026-10-21 | 08:00~08:15 | THE GLOBAL STROKE INVESTMENT CASE: STRENGTHENING STROKE CARE SYSTEMS AND IMPROVING CLINICAL OUTCOMES | Maria Grupper (Switzerland)( WSO Executive Director) | - |
| 2026-10-21 | 08:15~08:30 | THE GLOBAL STROKE BURDEN, THE EVIDENCE GAP, AND WHY NOW IS THE MOMENT TO BUILD A COMPELLING INVESTMENT CASE | Bo Norrving (Sweden)(Lund University, Sweden) | - |
| 2026-10-21 | 08:30~08:45 | BUILDING THE EVIDENCE FOR STROKE INVESTMENT: METHODOLOGY, PROGRESS, AND FUTURE DIRECTIONS | Taskeen Khan (Switzerland)(World Health Organization) | - |
| 2026-10-21 | 08:45~09:00 | THE ROLE OF HEALTH ECONOMICS IN STROKE CARE: FROM CLINICAL EVIDENCE TO HEALTH SYSTEM DECISIONS | Francesca Pezzella (Italy)(San Camillo Hospital) | - |
| 2026-10-21 | 09:00~09:15 | DECISION-ANALYTIC APPROACHES TO STROKE CARE: LINKING CLINICAL EVIDENCE, COST-EFFECTIVENESS, AND HEALTH SYSTEM DECISION-MAKING | Bianca De Greef (Netherlands)(Philips) | - |
| 2026-10-21 | 09:15~09:30 | DISCUSSION | - | - |
| 2026-10-21 | 09:30~10:00 | BREAK | - | - |
| 2026-10-21 | 10:00~10:15 | TAIWAN CADASIL COHORT / NOTCH3 IMAGING-BASED SCREENING | Antony Chih-Hao Chen (Taiwan)(National Taiwan University Hospital) | - |
| 2026-10-21 | 10:15~10:30 | MOYAMOYA GWAS / RNF213 MULTI-OMICS | Satoru Miyawaki (Japan)(The University of Tokyo) | - |
| 2026-10-21 | 10:30~10:45 | DIGITAL THERAPEUTICS FOR POST-STROKE VISUAL FIELD DEFECTS | Dong-Wha Kang (Korea, Republic of)(Asan Medical Center) | - |
| 2026-10-21 | 10:45~11:00 | STROKE PHARMACOGENOMICS: CURRENT EVIDENCE AND FUTURE DIRECTIONS | ay Chol Choi (Korea, Republic of)(Jeju National University Hospital, Jeju National University College of Medicine) | - |
| 2026-10-21 | 11:00~11:30 | DISCUSSION | - | - |
| 2026-10-21 | 11:30~13:00 | LUNCH & BREAK | - | - |
| 2026-10-21 | 13:00~13:15 | STEPWISE APPROACH OF ENDOVASCULAR THERAPY FOR INTRACRANIAL ATHEROSCLEROTIC DISEASE-RELATED LARGE VESSEL OCCLUSION (ICAD-RELATED LVO) IN ACUTE ISCHEMIC STROKE | Yen-Heng Lin (Taiwan)(National Taiwan University Hospital) | - |
| 2026-10-21 | 13:15~13:30 | THROMBECTOMY IN PATIENTS WITH PRE-STROKE DISABILITY | Thanh Phan (Australia)(Monash Health) | - |
| 2026-10-21 | 13:30~13:45 | POST-EVT BLOOD PRESSURE MANAGEMENT: SECONDARY ANALYSES AND FUTURE PERSPECTIVES OF THE OPTIMAL-BP TRIAL | Hyo Suk Nam (Korea, Republic of)(Yonsei University College of Medicine) | - |
| 2026-10-21 | 13:45~14:00 | ACUTE REPERFUSION THERAPY | Geoffrey Donnan (Australia)(Austin Hospital) | - |
| 2026-10-21 | 14:00~14:30 | DISCUSSION | - | - |
| 2026-10-21 | 08:00~08:10 | 구연)NETS-INDUCED CGAS-STING ACTIVATION CONTRIBUTES TO ENDOTHELIAL DYSFUNCTION AND GLYCOCALYX DEGRADATION IN BRAIN ARTERIOVENOUS MALFORMATIONS | Tianqi Tu (China)(The Affiliated Hospital, Southwest Medical University) | - |
| 2026-10-21 | 08:10~08:20 | 구연)RESIDUAL THROMBOTIC RISK AFTER ISCHEMIC STROKE IS ASSOCIATED WITH A PERSISTENT ACKR3 (CXCR7)-LINKED PHENOTYPE | Ooiean Teng (Singapore)(National University of Singapore) | - |
| 2026-10-21 | 08:20~08:30 | 구연)MACROPHAGE-DERIVED SCD13 DRIVES CHRONIC BLOOD-BRAIN BARRIER LEAKAGE VIA THE GPCR-SRC-ABL1 SIGNALING AXIS AFTER ISCHEMIC STROKE | Yuhualei Pan (China)(Department of Neurology,Shanghai East hospital,School of Medicine,Tongji University) | - |
| 2026-10-21 | 08:30~08:40 | 구연)A NOVEL PATHOPHYSIOLOGICALLY RELEVANT MOUSE MODEL OF CEREBRAL VENOUS SINUS THROMBOSIS BASED ON PHOTOTHROMBOSIS COMBINED WITH IN SITU INJECTION | Chengbin Zhou (China)(Ruijin Hospital, Shanghai Jiao Tong University School of Medicine) | - |
| 2026-10-21 | 08:40~08:50 | 구연)MODULATING NITRO-OLEIC ACID-PPARGAMMA SIGNALING AXIS TO ENHANCE BLOOD-BRAIN BARRIER INTEGRITY AND IMPROVE NEUROVASCULAR OUTCOMES IN ISCHEMIC STROKE | ejie Yin (United States of America)(University of Pittsburgh) | - |
| 2026-10-21 | 08:50~09:00 | 구연)LIPID PEROXIDATION-DRIVEN MICROGLIAL STATE TRANSITION AGGRAVATES VASCULAR INSTABILITY IN BRAIN ARTERIOVENOUS MALFORMATIONS | Zhenghong Peng (China)(The Affiliated Hospital, Southwest Medical University) | - |
| 2026-10-21 | 09:00~09:10 | 구연)MT200605: A NOVEL BIFUNCTIONAL NEUROPROTECTANT FOR ISCHEMIC STROKE | Yongzhen Liu (China)(Nanjing University ) | - |
| 2026-10-21 | 09:10~09:20 | 구연)LEUKOCYTE GENE EXPRESSION SIGNATURES OF BDNF, VEGFA, GAP43, SIRT1, AND HIF1A ASSOCIATE WITH FUNCTIONAL RECOVERY AFTER ISCHEMIC STROKE | Dragoș-Mihai Corcan (Romania)(Iuliu Hațieganu University of Medicine and Pharmacy) | - |
| 2026-10-21 | 09:20~09:30 | 구연)INTRAVENOUS AUTOLOGOUS BONE MARROW DERIVED STEM CELL INFUSION IN CHRONIC STROKE | Himanshu Koundal (India)(All India Institute of Medical Sciences) | - |
| 2026-10-21 | 09:30~10:00 | BREAK | - | - |
| 2026-10-21 | 10:00~10:25 | EVOLUTION OF REPERFUSION THERAPY IN ACUTE ISCHEMIC STROKE: FROM PAST ACHIEVEMENTS TO FUTURE DIRECTIONS | Werner Hacke (Germany)(U Heidelberg) | - |
| 2026-10-21 | 10:25~10:40 | INTRAVENOUS THROMBOLYSIS: FROM NINDS TO FUTURE | Thang Huy Nguyen (Viet Nam)(The People 's 115 Hospital) | - |
| 2026-10-21 | 10:40~10:55 | INDIVIDUALIZED PREVENTION OF BLEEDING COMPLICATIONS AFTER THROMBOLYSIS | Andrea Zini (Italy)(IRCCS Istituto Delle Scienze Neurologiche di Bologna) | - |
| 2026-10-21 | 10:55~11:10 | OPTIMIZED TREATMENT OF BASILAR ARTERY OCCLUSION | Yunyun (Carol) Xiong (China)(Beijing Tiantan Hospital, Capital Medical University) | - |
| 2026-10-21 | 11:10~11:30 | DISCUSSION | - | - |
비고
*사전등록 (2026년 8월 5일까지): 일반참가자 비회원 A 770달러/ 일반참가자 비회원 B 440달러/ 일반참가자 회원 A 550달러/ 일반참가자 회원 B 330달러/ 관련 의료인(간호사·젊은 연구자) A 330달러/ 관련 의료인(간호사·젊은 연구자) B 110달러/ 뇌졸중 지원단체 회원 100달러/ 학생 150달러*일반등록 (2026년 8월 6일부터 9월 30일까지): 일반참가자 비회원 A 880달러/ 일반참가자 비회원 B 605달러/ 일반참가자 회원 A 715달러/ 일반참가자 회원 B 495달러/ 관련 의료인(간호사·젊은 연구자) A 395달러/ 관련 의료인(간호사·젊은 연구자) B 165달러/ 뇌졸중 지원단체 회원 100달러/ 학생 150달러*현장등록 (2026년 10월 1일부터): 일반참가자 비회원 A 990달러/ 일반참가자 비회원 B 660달러/ 일반참가자 회원 A 825달러/ 일반참가자 회원 B 550달러/ 관련 의료인(간호사·젊은 연구자) A 450달러/ 관련 의료인(간호사·젊은 연구자) B 220달러/ 뇌졸중 지원단체 회원 100달러/ 학생 150달러
문의처
담당자
김희영
연락처
0505-277-1919
이메일
stroke@stroke.or.kr